NEW YORK (GenomeWeb News) – CellAura will provide its fluorescent reagents to Cisbio Bioassays for use with its non-radioactive assays for cellular studies, CellAura said today.

Under the agreement, CellAura will develop a number of reagents for Cisbio's Tag-lite platform, which is used for studies of cell surface receptor dimerization and ligand binding.

CellAura, a spin-out from the University of Nottingham, will retain the rights for the reagents developed for use in its own range of assays for certain markets.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The president of France's National Research Agency has resigned, according to Nature News.

A senator wants a "right-to-try" provision in the US Food and Drug Administration funding bill, but an ethicist says at Stat News that it would undermine the role of clinical trials.

In PNAS this week: red algae Porphyra umbicalis genome, deep neural network model for sequencing peptides, and more.

The Guardian's Barbara Ellen has tried out some DNA testing services to see whether they provide valuable information.